Innovating Solutions to
Accelerate Drug Development
Efferent Labs® offers a live, cellular data acquisition platform that radically alters the landscape of pre-clinical research in animals
We are focused on cell-based data platforms for life sciences
At Efferent labs, we are pioneering drug development through groundbreaking, real-time biosensing technology. Our CytoComm® biosensor platform delivers continuous, actionable molecular-level data that transforms how pharmaceutical companies make critical R&D decisions. By Providing immediate feedback on drug responses and reducing reliance on traditional animal testing methods, we’re accelerating the path to market while advancing ethical research practices. With CytoComm®, we’re not just improving drug development— we’re redefining it.
Efferent Labs® offers an in vivo cellular data acquisition platform
Partners · Investors
Accelerate drug development
Efferent’s Living Informatics combines cutting edge technologies and materials with high powered computing capability to harvest and analyze in vivo data that provides never before available insight into cellular function and activity
Our work is based on the fact that living cells can tell us more about life processes than any instrument can
Provide more data and higher quality data to
the researcher
Our platform allows the researcher to obtain real-time molecular level data that has until now, been unobtainable. As a result, researchers and drug developers can make timely, data informed, decisions.
Efferent Labs® is always looking for qualified professionals to assist with our discoveries
We answer all email and requests as they come in. If you have an urgent matter or would like to place an order please click the link below to give us a call.